Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. (CRVS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CRVS · as of Jun 8, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
2
12 Months
Buy/Sell ratio
1.00
Buy/Sell (by trades)
Overall sentiment
Corvus Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CRVS insider buying and selling by quarter
CRVS insider selling · CRVS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CRVS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CRVS executive sell shares · CRVS board member insider trading · CRVS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 18, 2026 | MILLER RICHARD A MD President and CEO · Director | Purchase | 1,932 | $23K | Form 4 |
| May 18, 2026 | MILLER RICHARD A MD President and CEO · Director | Purchase | 5,000 | $60K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $32K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $25K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $37K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $14K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $15K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $39K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $41K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $49K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $30K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $54K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $188K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 15,000 | $146K | Form 4 |
| Jan 28, 2026 | Thompson Peter A. Director | Option | 30,000 | $450K | Form 4 |
| Jun 27, 2025 | ORBIMED ADVISORS LLC Director | Other | 1,397,684 | $4.89M⚡ | Form 4 |
| Jun 27, 2025 | ORBIMED ADVISORS LLC Director | Sale | 1,176,332 | $4.89M⚡ | Form 4 |
| Jun 27, 2025 | Thompson Peter A. Director | Other | 1,397,684 | $4.89M⚡ | Form 4 |
| Jun 27, 2025 | Thompson Peter A. Director | Sale | 1,176,332 | $4.89M⚡ | Form 4 |
| Jun 4, 2025 | Jones William Benton See Remarks | Option | 19,357 | $68K | Form 4 |
| May 7, 2025 | MILLER RICHARD A MD President and CEO · Director | Option | 559,073 | $1.96M⚡ | Form 4 |
| May 10, 2024 | MILLER RICHARD A MD President and CEO · Director | Gift | 302,016 | — | Form 4 |
| May 6, 2024 | Jones William Benton See Remarks | Purchase | 20,000 | $35K | Form 4 |
| May 6, 2024 | MILLER RICHARD A MD President and CEO · Director | Purchase | 577,634 | $1000K | Form 4 |
| May 15, 2023 | Grais Linda Director | Purchase | 10,000 | $25K | Form 4 |
MILLER RICHARD A MD
President and CEO · Director
Date
May 18
Shares
1,932
Price
$12.01
Value
$23K
MILLER RICHARD A MD
President and CEO · Director
Date
May 18
Shares
5,000
Price
$12.05
Value
$60K
ORBIMED ADVISORS LLC
Director
Date
Jun 27
Shares
1,397,684
Price
$3.50
Value
$4.89M ⚡
ORBIMED ADVISORS LLC
Director
Date
Jun 27
Shares
1,176,332
Price
$4.16
Value
$4.89M ⚡
Thompson Peter A.
Director
Date
Jun 27
Shares
1,397,684
Price
$3.50
Value
$4.89M ⚡
MILLER RICHARD A MD
President and CEO · Director
Date
May 7
Shares
559,073
Price
$3.50
Value
$1.96M ⚡
MILLER RICHARD A MD
President and CEO · Director
Date
May 10
Shares
302,016
Price
—
Value
—
Jones William Benton
See Remarks
Date
May 6
Shares
20,000
Price
$1.73
Value
$35K
MILLER RICHARD A MD
President and CEO · Director
Date
May 6
Shares
577,634
Price
$1.73
Value
$1000K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CRVS insider trading
CRVS insider trades
Corvus Pharmaceuticals, Inc. (CRVS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Thompson Peter A. (Director), MILLER RICHARD A MD (President and CEO · Director), ORBIMED ADVISORS LLC (Director). Over the past 12 months, 3 insiders have filed transactions with the SEC. CRVS insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Corvus Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CRVS insider trading · 5 questionsThe insiders of Corvus Pharmaceuticals, Inc. (CRVS) include executives and directors such as Thompson Peter A. (Director), MILLER RICHARD A MD (President and CEO · Director), ORBIMED ADVISORS LLC (Director), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026